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Abstract 
 Psychological dependence involves a desire to use a drug to avoid the unpleasant withdrawal 
syndrome that results from cessation of exposure to it. Alcohol withdrawal syndrome is one of the most 
feared complications of alcohol addiction and sometimes can be fatal if not treated properly. 
Withdrawal syndrome is characterized by neurological hyperexcitability, which can lead to severe 
psychological and neurological symptoms. A survey was conceived in order to monitor the efficiency of 
several drug associations (Clonidine, Midazolam, IV ethanol), which were administered at the 
beginning of intensive therapy admission of achohol addicts. By comparing the postoperative evolution 
parameters and complications incidences for these patients (such as the hospitalization duration in AIT 
department, the tracheobronchitis incidence, complications as sepsis, pneumonia and cardiac 
complications), we managed to determine which treatment is the most beneficial for these cases. 
Benzodiazepines are frequently used for pharmacological therapy of alcohol addicted patients. In our 
study Midazolam was very efficient, compared to other therapies. When administered for a maximum of 
7 days, the inccidence of side effects remains minimal. 
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Introduction 
Alcohol withdrawal syndrome is one of the most feared complications of alcohol addiction and 
sometimes can be fatal if not treated properly, mortality reaching up to 15%. Withdrawal syndrome is 
characterized by neurological hyperexcitability due to reduced GABA-ergic activity and increased 
glutaminergic and noradrenergic activity. 
Excess alcohol consumption is a serious health problem, that not only affects the mental health  
of the persons concerned, but may contribute to multi-systemic structural and/ or functional alterations, 
such as digestive tract organs and annexes, heart and so forth.  
In this study we intend to establish the benefit of the multiple mesures and drugs administered in 
order to prevent complications for these high risk patients.  
 
Matherials and Methods: 
A survey was conceived in order to monitor the efficiency of several drug associations, which 
were administered at the beginning of intensive therapy admission (Clonidine, Midazolam, i.v. ethanol). 
By comparing the postoperative evolution parameters and complications incidences for these patients 
(such as the hospitalization duration in AIT department, the tracheobronchitis incidence, complications 
as sepsis, pneumonia and cardiac complications), we managed to determine which treatment is the most 
beneficial for these cases.  
Postoperative withdrawal syndrome prevention and treatment have been tested by substitution 
with alcohol (1-2 mg/dl), monotherapy with Midazolam (0.2-0.4mg/kg/h) or Clonidine (1-2mg/dl). 150 
patients were classified in 3 groups whom was administered one of the 3 forms of treatment. The results 
of group which received alcohol substitution were considered reference for the comparison. 
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Results: 
Statistical analysis of the results revealed that the group that received Midazolam monotherapy, 
showed best postoperative results, followed by a reduced number of withdrawal syndrome symptoms 
(with 45%), a shorter duration of hospitalization in AIT department (with 5.2 days), less respiratory 
complications, delirium tremens and lower mortality (6% versus 12%), when compared with i.v. achohol 
group. 
The patients in the group that received Clonidine, necessitated supplementary sedation, usually 
with benzodiazepines. Even so, the results were still better then the group with received alcohol 
sustitution, with 32% reduction of withdrawal syndrome symptoms,a shorter duration of hospitalization 
in AIT department (with 4.5 days)and lower mortality (8% versus 12%).  
 
Discusions 
Alcohol addiction prevalence in surgical patients is very high. Addiction is a compulsion for 
rewarding stimuli (associated with positive reinforcement), which is essentially an intense desire or 
craving. Psychological dependence involves a desire to use a drug or perform a behavior to avoid the 
unpleasant withdrawal syndrome (negative reinforcement) that results from cessation of exposure to it 
(1, 2, 3). Alcohol withdrawal syndrome is one of the most feared complications of alcohol addiction and 
sometimes can be fatal if not treated properly, mortality reaching up to 15% (1, 4). Addicted patients 
have a higher morbidity and exhibitmore complications, such as infections and cardiovascular 
complications. In these patients, the alcohol recede during hospitalization, the surgical stress, the 
hypotension, the hypoxia or the perioperative pain, may hasten the onset of withdrawal syndrome (1, 5, 
6). 
Surgeons tend to under-recognize psychiatric disorders until they interfere with evaluation and 
treatment. Often, a patient’s psychiatric history is not obtained or considered until problems arise post-
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operatively. Chronic alcohol abuse and withdrawal syndrome, are associated with severe postoperative 
complications as pneumonia, infections, difficult healing, sepsis, cardiac complications (heart failure, 
ischemia, arrhythmias) (7). They also develop severe hemorrhages and require a higher volume of blood 
for transfusions (7, 8). 
 Withdrawal syndrome is characterized by neurological hyperexcitability due to reduced 
GABAergic activity and increased glutaminergic and noradrenergic activity. There are also numerous 
mechanisms of cortical inhibitory pathways depression, leaving the excitatory pathways to function 
uncontrolled (1, 9, 10). 
 In these patients, postoperative complications risk can be minimized. Tonnensen proved in one 
survey, that a month withdrawal program that includes disulfiram, before surgery, decreases 
postoperative complications in patients that undergo gastrointestinal surgery (11). Minimizing 
intraoperative stress also decreases postoperative morbidity (12). Also, an important part belongs 
toadministrationof agents that decrease the production of cortisol (small alcohol doses, morphine, 
ketoconazole, propofol) (13). 
Postoperative withdrawal syndrome prevention in patients with UIB 
 Part of the patients with UIB requires emergency surgery and therefore withdrawal syndrome 
prevention shortens the hospitalization in AIT department. During a survey, were used and compared 
more drug associations, which were administered at the beginning of intensive therapy admission: 
flunitrazepam-clonidine, chormethiazol-halperidol, flunitrazepam-haloperidol or ethanol, then being 
appreciated the hospitalization duration in AIT department, the tracheobronchitis incidence, 
complications as sepsis, pneumonia and cardiac complications. The patientswith chlormethiazol-
haloperidol, developed tracheobronchitis (14). Although benzodiazepines are recommended as first line 
treatment in withdrawal syndrome prevention, administration of iv ethanol, represents a prophylactic 
alternative in many AIT departments. Many claim that it would realize prevention, without excessive 
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sedation as benzodiazepines. A comparison survey was realized, focusing on sedative effects. The 
survey conclusion was that ethanol has no advantage as against diazepam and that its efficiency was not 
proved (2, 15). Another survey proved that ethanol vapors inhalation, may reduce postoperative ethanol 
withdrawal syndrome symptoms if diazepam treatment doesn’t work (16). Clonidine efficiency has been 
evaluated in intrathecal or oral administration as a supplement to spinal anesthesia with lidocaine, in 
postoperative withdrawal syndrome prevention. The conclusion was that 150 mg of intrathecal/oral 
clonidine prevent the onset of postoperative withdrawal syndrome, better than 10 mg of oral diazepam 
(17, 18). 
Treatment for the patient hospitalized for UIB, that presents ethanol withdrawal syndrome 
 An important percentage of the patients with UIB, presents at hospital admission or develop 
during hospitalization ethanol withdrawal, due to the high rate of chronic ethanol consumption in this 
group of patients.  
 Severe withdrawal syndrome risk factors are: the chronic alcohol consumption, history of 
generalized convulsions or delirium tremens, while symptoms as anxiety, unrest, tremor, excessive 
perspiration, altered state of consciousness, hallucinations, show a severe withdrawal syndrome (19). 
Supportive measures have a major part in ethanol withdrawal patient management. Reevaluation of the 
patient’s state has to be done repeatedly, since many symptoms of the withdrawal coexist, can be mimed 
or complicated by other conditions, infections, trauma, metabolic disorders, hepatic failure, digestive 
hemorrhages. When we confront with altered mental state without a defined cause, we have to perform a 
lumbar puncture or a CT scan, in order to exclude other diagnostic possibilities, especially in patients 
with fever and withdrawal syndrome.  
The patients need to be placed into a quiet place, in lateral position (swimmer position). It may 
be necessary for those patients who suffer from delirium tremens, for their protection and for those who 
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take care of them. Blood volume deficits have to be calculated and replaced; if there are no 
contraindications, isotonic i.v. fluids are administered until the patients become clinically euvolemics. 
Before administering solutions that contain glucose, Thiamine 100 mg iv or im have to be administered 
in order to decrease the risk of Wernicke encephalopathy or Korsakoff syndrome. 
Table I 
Syndrome 
 
 
Clinincal menifestations Time 
Minor symptoms:  
They ameliorate in 24-48 h 
 
Tremors, anxiety, headaches, diaphoresis, 
palpitations, gastrointestinal symptoms, 
diarrhea, anorexia 
6-36 h 
Convulsions- in 3% of the chronic 
alcohol drinkers 
Generalized convulsions, tonic-clonics, rare 
status epileptic (3% of those with seizures) 
6-48 
Hallucinations – start in 12-24h of 
abstinence and disappear in 24-48 h 
(when delirium tremens starts) 
The hallucinations are frequently visual; 
they can also be acoustic and tactile. 
48-96 h 
Delirium tremens- in 5%; mortality 
5% especially because of the 
arrhythmias or the aspiration 
pneumonia 
Delirium tremens produces hallucinations, 
disorientation, tachycardia, arterial 
hypertension, fever, unrest, and diaphoresis. 
The patients are dehydrated because of the 
diaphoresis, hyperthermia, vomit, and 
tachypnea. Hypokalemia is frequent.  
 
 
 Multivitamins and folate are used as a regular base. Potassium, magnesium, glucose, phosphate 
deficiencies have to be corrected if necessary. Among the criteria that lead to AIT admission, are: 
- Patients older than 40 years, with concurrent diseases like heart failure, myocardial ischemia and 
pectoral angina; 
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- Hidroelectrolytic imbalances with EEG alterations, alterations of the acid base balance; 
- Hemodynamic instability, respiratory failure, hypoxemia, hypercapnia; 
- Severe infections; 
- Gastrointestinal pathology, pancreatitis, superior digestive hemorrhage, peritonitis, persistent 
hyperthermia; 
- Rhabdomyolysis, renal failure, delirium tremens history. 
  Table II- Doses 
 “Clinical Institute Withdrawal 
Assessment for Alcohol” revised score (CIWA-
Ar) uses 10 terms to quantify the severity of 
withdrawal syndrome and allows the 
classification of the patients in 3 different 
categories: mild (no hospitalization required), 
moderate, severe. Severe forms require hospitalization in AIT hospital department (20, 21, 22). 
This score is useful but not sufficient, most of the patients having associated comorbidities. It 
does not take in consideration delirium tremens, which could have other etiologies beside ethanol 
withdrawal. It’s a numeric scale which assigns to symptoms a value regarding their severity, but it’s 
quite subjective (23, 24, 25). In refractory withdrawal, barbiturates are associated, especially 
phenobarbital. Propofol may be also used. The usage of phenobarbital and propofol, requires AIT 
monitoring and mechanical ventilation (26). Among other pharmacological agents which have been 
proposed is Baclofen, a selective agonist of the GABA – B receptor and owns antispasmodic effects 
through this mechanism. It seems to be efficient as benzodiazepines (27). 
 The most used antipsychotics are phenothiazines and butirophenones, which decrease 
convulsions but have to be used with extreme caution. Antiepileptic drugs: in studies is used 
Drug name Dose in mg 
Chlordiazepoxide 25 
Diazepam 5 
Lorazepam 0.75-1 
Oxazepam 15 
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carbamazepine which is thought to be as efficient as lorazepame, but there is not enough evidence to 
certify its use (23, 28, 29, 30).  
 Chlormethiazole is a drug related to thiamine, which acts as a sedative-hypnotic, muscle relaxant 
and anticonvulsant. Other proposed agents are sodium valproate, gabapentin, gama-hydroxybutyrate (1, 
31, 32). Other drugs, as beta-agonists or neuroleptics might bring some benefits, but cannot be used in 
monotherapy (33). 
Beta-blockers increase the risk of hallucinations and clonidine increases the frequency of 
nightmares, while their efficiency is not well enough documented. Neuroleptic drugs increase the risk of 
convulsions. Magnesium sulfate or meprobamate have numerous side effects and their usage is not 
recommended. There are no specific recommendations regarding hydration. Excessive intake of sodium 
containing solutions, increases the risk of pulmonary edema in patients with cardiac diseases. B1 
vitamin deficiency is frequent and may cause severe complication, that’s why oral intake of B1 vitamin 
is recommended, in high doses, in order to compensate poor absorption. IV administration is preferred if 
the patient has a seriously altered nutritional status or in severe complications as Gayet-Wernicke 
encephalopathy, even if there were reported important anaphylactic reactions after vitamin injection. 
Reestablishing proper hydroelectrolitic balance, along with continuous monitoring of vital 
functions and respiratory support, if necessary, has the effect of decreasing mortality in delirium tremens 
below 3% (19, 34- 36). 
Conclusions 
Benzodiazepines are frequently used for pharmacological therapy of alcohol addicted patients. In 
our study Midazolam was very efficient, compared to other therapies. When administered for a 
maximum of 7 days, the inccidence of side effects remainsminimal (19). They act on GABA-ergic 
receptors. Lorazepam, Oxazepam or Tamazepam are used frequently in patients with advanced hepatic 
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diseases, because they lack metabolic effects and they have a short half-life. Oral administration is the 
preferred way of administration. If bewildered, the i.v. way is used. If not possible, Lorazepam i.m. is 
used. Young patients with little comorbidity may be only slight sedated. Old patients, with comorbidities 
must be sedated and monitored in AIT department. Symptomatic therapy is reserved for withdrawal 
symptoms and represents the choice for young patients. They receive lower doses of benzodiazepines 
and the treatment period is shorter. 
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